Areas of Research in 2018-19 include Combination therapy, CARP Inhibitors, radiopharmaceuticals

Heather H. Cheng MD, PhD, Seattle Cancer Care Alliance, discusses Areas of Research in 2018-19 include Combination therapy, CARP Inhibitors, radiopharmaceuticals at Annual Meeting 2018.

Areas of Research in 2018-19 include Combination therapy, CARP Inhibitors, radiopharmaceuticals

MOASC Awards $25,000 Research Grant from AVEO Oncology to Dr. Peter Zang, MD of City of Hope 2025 Cary Presant, MD Investigator Award

MRI’s Role in Prostate Cancer Diagnosis, a 3-Year Study Breakthrough

Overview of SYNC-T Technology from Syncromune in Prostate Cancer Treatment – Charles Link, MD

Areas of Research in 2018-19 include Combination therapy, CARP Inhibitors, radiopharmaceuticals

Related Posts

MOASC Awards $25,000 Research Grant from AVEO Oncology to Dr. Peter Zang, MD of City of Hope 2025 Cary Presant, MD Investigator Award

MRI’s Role in Prostate Cancer Diagnosis, a 3-Year Study Breakthrough

Overview of SYNC-T Technology from Syncromune in Prostate Cancer Treatment – Charles Link, MD